GM1 Gangliosidoses: Clinical Trials

1 trial for GM1 Gangliosidoses, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow GM1 Gangliosidoses: new trials by email Literature Review of GM1 Gangliosidoses trials Research Report on GM1 Gangliosidoses

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Synergistic Enteral Regimen for Treatment of the Gangliosidoses
miglustat, Ketogenic Diet - GM1 Gangliosidoses, GM2 Gangliosidoses
Phase 4TerminatedUniversity of Minnesota162015-12-222021-04-14

Narrower conditions

Gangliosidoses (1)  ·  Gangliosidoses, GM2 (1)  ·  Gangliosidosis, GM1 (1)  ·  Sandhoff Disease (1)  ·  Tay-Sachs Disease (1)  ·  Tay-Sachs Disease, Juvenile (1)

Broader conditions

Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Central Nervous System Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Lipid Metabolism Disorders (1)  ·  Lipid Metabolism, Inborn Errors (1)  ·  Lipidoses (1)  ·  Lysosomal Storage Diseases (1)  ·  Lysosomal Storage Diseases, Nervous System (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Nervous System Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Diet, Ketogenic (1)  ·  miglustat (1)

Sponsors

University of Minnesota (1)

Countries

United States (1)

Top investigators

Jeanine R. Jarnes, PharmD (1)

Results publications

PMID 28476546

NIH funding

U54NS065768 (1)